DPP4 and type 2 diabetes mellitus: In drug-naïve subjects with type 2 diabetes who were treated with diet and life style, the DPP-4 inhibitors were examined as monotherapy in placebo-controlled 24–26 week studies with a total number of 2,328 subjects [Table 2; (66–70)].